GlassScriptPhysician profile
Nicholas Teman
NPI 1841452554
$34,618.74
in general payments reported to CMS, 2019-2025
23 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,941 · 2020: $271 · 2021: $1,212 · 2022: $1,420 · 2023: $1,894 · 2024: $9,837 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $5,370 · Consulting Fee: $5,254 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,650.13 |
| Food and Beverage | $5,369.73 |
| Consulting Fee | $5,254.16 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $12,599.43 | 2019-2025 | Evoque |
| Alexion Pharmaceuticals, INC. | $4,495.42 | 2023-2024 | |
| Intuitive Surgical, INC. | $4,446.86 | 2025 | |
| Medtronic Vascular, INC. | $3,292.61 | 2019 | |
| Abbott Laboratories | $2,601.62 | 2019-2025 | Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $2,053.72 | 2021-2025 | Impella |
| Atricure, INC. | $1,828.94 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Davol INC. | $541.76 | 2021-2023 | |
| Medtronic, INC. | $529.15 | 2021-2023 | Corevalve Evolut R |
| Angiodynamics, INC. | $480.86 | 2022-2025 | Alphavac, Angiovac |
| Hemosonics LLC | $474.31 | 2019-2022 | |
| Corcym INC | $354.59 | 2022-2023 | Perceval |
| Becton, Dickinson and Company | $283.33 | 2025 | |
| Bolton Medical INC | $280.88 | 2022-2025 | Thoraflex Hybrid |
| Ethicon US, LLC | $141.83 | 2023 | Prolene, Echelon; Endopath, Vistaseal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $108.23 | 2022 | |
| Livanova USA, INC. | $42.65 | 2021 | |
| Werfen USA LLC | $23.47 | 2021 | |
| Haemonetics Corporation | $20.22 | 2025 | Teg6s Hemostasis System |
| Medistim USA, INC. | $18.86 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Teman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.